Ignite Creation Date:
2024-05-06 @ 12:18 AM
Last Modification Date:
2024-10-26 @ 10:47 AM
Study NCT ID:
NCT01542788
Status:
COMPLETED
Last Update Posted:
2014-05-19
First Post:
2012-02-17
Brief Title:
Sofosbuvir Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant Interferon Ineligible or Unwilling to Take Interferon
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Hepatitis C |